Caricamento...
Genomic approaches to identifying targets for treating β hemoglobinopathies
Sickle cell disease and β thalassemia are common severe diseases with little effective pathophysiologically-based treatment. Their phenotypic heterogeneity prompted genomic approaches to identify modifiers that ultimately might be exploited therapeutically. Fetal hemoglobin (HbF) is the major modula...
Salvato in:
| Pubblicato in: | BMC Med Genomics |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4517356/ https://ncbi.nlm.nih.gov/pubmed/26215470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12920-015-0120-2 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|